Ceribell

Ceribell Enterprise Value

The Enterprise Value (EV) of Ceribell (CBLL) as of Oct 29, 2026 is 559.55 M USD. In the previous year, Enterprise Value (EV) was 524.19 M USD — a change of 6.75% (higher).

Enterprise Value

559.55 MUSD

YoY

6.75%

Last updated:

Enterprise Value (EV) of Ceribell is 2025 559.55 M USD. Enterprise Value (EV) of Ceribell was 2024 524.19 M USD. It decreases by 6.75% higher compared to the previous year.

The Ceribell Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2022
645.98 M USD
Jan 1, 2023
676.34 M USD
Jan 1, 2024
524.19 M USD
Jan 1, 2025
559.55 M USD
The Ceribell Enterprise Value history
YEAREnterprise ValueYoY
559.55 MUSD+6.75%
524.19 MUSD-22.50%
676.34 MUSD+4.70%
645.98 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ceribell Stock analysis

What does Ceribell do? Ceribell, Inc. generates revenue through its Ceribell System, a point-of-care EEG platform designed for acute care settings. The system combines portable hardware with AI-powered algorithms, including the Clarity AI algorithm that provides real-time EEG interpretation, bedside alerts, and continuous monitoring for status epilepticus. Hospitals and healthcare providers purchase the Ceribell System to improve neurological diagnosis and management, particularly for patients with acute conditions requiring rapid seizure detection. The Ceribell EEG Portal is also offered as part of the solution to facilitate data access and management. The company's primary customers are healthcare institutions seeking to enhance patient care efficiency through advanced neurological monitoring. By enabling early detection and continuous monitoring, the Ceribell System supports precise treatment decisions and reduces hospital resource strain. The Clarity AI algorithm is a key differentiator, delivering real-time insights that address critical unmet needs in acute neurological care. Ceribell, Inc. focuses on transforming diagnosis and management of serious neurological conditions through its proprietary technology. The Ceribell System's portability and rapid deployment make it suitable for acute care environments where timely intervention is crucial. Healthcare providers use the system to monitor patients with suspected seizures, leveraging the AI-driven insights for immediate clinical action. Ceribell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ceribell stock

Enterprise Value (EV) of Ceribell is 559.55 M USD in 2025.

Enterprise Value (EV) of Ceribell changed from 524.19 M USD to 559.55 M USD, representing a 6.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Ceribell since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Ceribell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ceribell

All Key Metrics — Ceribell